disclosure
Awaiting price reaction for this filing.
The company has submitted to BSE a certificate from its Registrar and Share Transfer Agent (RTA), MAS Services Limited, as required under SEBI's Depositories Regulations. The certificate confirms that all share dematerialisation requests received from Depository Participants between 1 October 2025 and 31 December 2025 were processed, and the relevant certificates were mutilated/cancelled and the depository's name substituted in the register of members, all within the 15-day deadline. The filing is a routine quarterly compliance submission signed by the Company Secretary. The document also reflects that the company has been renamed from Advik Laboratories Limited to MPS Pharmaa Limited.
This is a routine regulatory compliance filing with no material impact on the business, financials, or share price. It simply reaffirms that share transfer and dematerialisation activities during the October–December 2025 quarter were handled within SEBI-mandated timelines.